Bio-Rad Laboratories ABIO.NValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, Bio-Rad Laboratories A (BIO.N) trades at a P/E of 42.50x, P/B of 1.32x, P/S of 3.65x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 72nd percentile over the trailing 10Y window (vs. 66th percentile over 3Y); P/B sits at the 33rd percentile over the trailing 10Y window (vs. 84th percentile over 3Y); P/S sits at the 44th percentile over the trailing 10Y window (vs. 85th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 78th percentile within its industry and the 81st percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 3.12%, ranking at the 90th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 39.4 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here lean heavily on buybacks rather than cash dividends. Bio-Rad Laboratories A operates in the Manufacturing sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NYSE: BIO · BIO
Want the full picture on whether Bio-Rad Laboratories A (BIO.N) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 42.50 | ||||||
| P/B (MRQ) | 1.32 | ||||||
| P/S (TTM) | 3.65 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 3.12% |